Heli Virsunen
Papers
2
Total Citations
51
H-Index
2
About
Heli Virsunen is a leading clinical researcher in radiation oncology, whose work has significantly advanced the treatment of localized prostate cancer through stereotactic body radiotherapy (SBRT). Her research focuses on the dosimetric optimization and clinical implementation of hypofractionated SBRT, a technique that delivers high-dose radiation in fewer, more precise sessions. Virsunen’s major contributions include the first Nordic clinical experience with SBRT for prostate cancer, demonstrating its safety and efficacy in a landmark 2017 study (26 citations). She also conducted a pivotal dosimetric comparison of four SBRT techniques in 2016 (25 citations), providing critical evidence for optimizing treatment delivery and minimizing toxicity. Her work has helped establish SBRT as a standard option for localized disease, improving patient convenience and outcomes. With her studies cited by peers worldwide, Virsunen’s research continues to shape clinical guidelines and inspire further innovation in precision radiotherapy, making her a key figure in the evolution of prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2